 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: February 2026
Volume 11 | Issue 2
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 11
Issue Published : 117
Article Submitted : 21318
Article Published : 8476
Total Authors : 22301
Total Reviewer : 802
Total Countries : 156
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Recent Pre - clinical advancements in nuclear medicine: pioneering the path to a limitless future |
| Authors Name: | Mani Pratap Singh , Chitra Sharma , Ashutosh Mishra , Rohit lalwani , Vanshu Saxena |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_208623
|
| Published Paper Id: | IJRTI2512089 |
| Published In: | Volume 10 Issue 12, December-2025 |
| DOI: | |
| Abstract: | Oncology theranostic practice is an intriguing field of molecular medicine with major implications for individualized treatment. Recent decades have seen significant advancements in this discipline, especially in the use of 177-Lu-radiolabeled to treat neuroendocrine tumors. Somatostatin analogs and, more recently, prostate-specific membrane-antigen targeted radionuclide treatment to treat prostate cancer. The development of this strategy was made possible by the encouraging clinical outcomes seen in these indications. Nuclear medicine is positioned for success due to the ongoing identification of new molecular actors in carcinogenesis, the creation of innovative radiopharmaceuticals, and the possible pairing of immunotherapy and theranostics drugs notable developments. There are three main components to theranostics' approach in oncology: (1) repurposing nuclear medicine drugs for different applications, (2) enhancing currently available radiopharmaceuticals, and (3) creating novel theranostics agents for tumor-specific antigens. |
| Keywords: | Nuclear medicine, Theranostics, Oncology, Immunotherapies |
| Cite Article: | "Recent Pre - clinical advancements in nuclear medicine: pioneering the path to a limitless future ", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.10, Issue 12, page no.a702-a709, December-2025, Available :http://www.ijrti.org/papers/IJRTI2512089.pdf |
| Downloads: | 000138 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2512089
Registration ID:208623
Published In: Volume 10 Issue 12, December-2025
DOI (Digital Object Identifier):
Page No: a702-a709 Country: Bijnor , Uttarpradesh, India Research Area: Medical Science Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2512089 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2512089 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2026 - All Rights Reserved - IJRTI | |||